Oncology Meeting Resources

ESMO Congress 2012

28 Sep - 02 Oct, Vienna, Austria

ESMO 2012 Congress

Please find below the links to all ESMO 2012 presentations that have an abstract, poster, slide set or webcast. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Search Meeting Resources by Keyword

 

 

Useful links

Presenter Presentation title Session title
Mohamad Mohty How to select amongst available options for the treatment of multiple myeloma
David Cunningham Welcome and introduction Industry Satellite: Sanofi: Choosing an optimal fit: Exploring treatments for the patient with metastatic colorectal cancer
Dirk Arnold Exploring the latest advances for metastatic CRC Industry Satellite: Sanofi: Choosing an optimal fit: Exploring treatments for the patient with metastatic colorectal cancer
Marc Peeters Clinical cases and panel discussion Industry Satellite: Sanofi: Choosing an optimal fit: Exploring treatments for the patient with metastatic colorectal cancer
David Ferry What to expect: Managing adverse effects of treatments for metastatic CRC Industry Satellite: Sanofi: Choosing an optimal fit: Exploring treatments for the patient with metastatic colorectal cancer
Marc Peeters Clinical cases and panel discussion Industry Satellite: Sanofi: Choosing an optimal fit: Exploring treatments for the patient with metastatic colorectal cancer
David Cunningham Optimizing evidence-based decisions in metastatic CRC Industry Satellite: Sanofi: Choosing an optimal fit: Exploring treatments for the patient with metastatic colorectal cancer
Marc Peeters Clinical cases and panel discussion Industry Satellite: Sanofi: Choosing an optimal fit: Exploring treatments for the patient with metastatic colorectal cancer
David Cunningham Closing remarks Industry Satellite: Sanofi: Choosing an optimal fit: Exploring treatments for the patient with metastatic colorectal cancer
Pier Francesco Ferrucci Chemosaturation with CHEMOSTAT: Clinically meaningful tumour responses and manageable toxicities in patients with cancers in the liver Industry Satellite: Delcath: Chemosaturation therapy: Creating new options in the management of patients with liver dominant disease
Bertrand Tombal Recent insights into cancer-related bone disease and its management in Europe Industry Satellite: Skeletal Care: Achieving excellence in the management of cancer-related bone disease: The Skeletal Care Academy charter for patient care
Sanjiv Agarwala Management of cancers in the liver: Potential bridge to the further treatment of the primary disease Industry Satellite: Delcath: Chemosaturation therapy: Creating new options in the management of patients with liver dominant disease
Steven O'Day Treatment of diffuse liver disease: A repeatable minimally invasive procedure Industry Satellite: Delcath: Chemosaturation therapy: Creating new options in the management of patients with liver dominant disease
Robert Pirker Welcome and introductions from the program chair Industry Satellite: Eli Lilly: Orchestrating progress in patients with advanced NSCLC: A symphony of views
H. Alexander Jr. Concentrated chemotherapy to the liver: The history of chemosaturation Industry Satellite: Delcath: Chemosaturation therapy: Creating new options in the management of patients with liver dominant disease